NETWORK META-ANALYSIS: COMPARATIVE EFFICACY OF BIOLOGICS IN THE TREATMENT OF BIOLOGIC-NAiVE JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引：0
|
作者：
Hibi, Toshihumi
Kamae, Isao
Pinton, Philippe
Ursos, Lyann
Iwakiri, Ryuichi
Hather, Greg
Patel, Haridarshan
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2019年 / 25卷
关键词：
D O I：
10.1093/ibd/izy393.043
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P038
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Biological Agents for Moderately to Severely Active Ulcerative Colitis A Systematic Review and Network Meta-analysis
    Danese, Silvio
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Lucenteforte, Ersilia
    Virgili, Gianni
    Moja, Lorenzo
    Bonovas, Stefanos
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (10) : 704 - +
  • [22] Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis
    Welty, Margaux
    Mesana, Laura
    Padhiar, Amie
    Naessens, Dominik
    Diels, Joris
    van Sanden, Suzy
    Pacou, Maud
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 595 - 606
  • [23] Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis
    Dignass, Axel
    Ainsworth, Claire
    Hartz, Susanne
    Dunnewind, Niels
    Redondo, Isabel
    Sapin, Christophe
    Kroep, Sonja
    Halfpenny, Nicholas
    Arca, Emanuele
    Hoque, Sami
    ADVANCES IN THERAPY, 2024, 41 (12) : 4446 - 4462
  • [24] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Xinlin Chen
    Jiangtao Hou
    Yujie Yuan
    Chaoyuan Huang
    Tianwen Liu
    Chuanwei Mo
    Haiwen Li
    Bin Chen
    Qian Xu
    Zhengkun Hou
    Weiling He
    Fengbin Liu
    BioDrugs, 2016, 30 : 207 - 217
  • [25] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Chen, Xinlin
    Hou, Jiangtao
    Yuan, Yujie
    Huang, Chaoyuan
    Liu, Tianwen
    Mo, Chuanwei
    Li, Haiwen
    Chen, Bin
    Xu, Qian
    Hou, Zhengkun
    He, Weiling
    Liu, Fengbin
    BIODRUGS, 2016, 30 (03) : 207 - 217
  • [26] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla C.
    Betts, Keith
    Eren, Devrim
    Tang, Wenxi
    Yin, Lei
    Gupte-Singh, Komal
    GASTROENTEROLOGY, 2022, 162 (07) : S603 - S603
  • [27] Comparative Effectiveness and Safety of Infliximab and Adalimumab for Ulcerative Colitis in Biologic-Naive Patients
    Singh, Siddharth
    Sangaralingham, Lindsey R.
    Heien, Herbert
    Anderson, Stephanie S.
    Shah, Nilay
    Loftus, Edward V.
    GASTROENTEROLOGY, 2015, 148 (04) : S175 - S176
  • [28] Efficacy and safety of advanced induction and maintenance therapies in patients with moderately to severely active Ulcerative Colitis: An indirect treatment comparison using Bayesian network meta-analysis
    Panaccione, R.
    Collins, E. B.
    Melmed, G. Y.
    Vermeire, S.
    Danese, S.
    Higgins, P. D. R.
    Zhou, W.
    Ilo, D.
    Sharma, D.
    Gonzalez, Y. Sanchez
    Wang, S. T.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I037 - I041
  • [29] EFFICACY AND SAFETY OF ADVANCED INDUCTION AND MAINTENANCE THERAPIES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INDIRECT TREATMENT COMPARISON USING BAYESIAN NETWORK META-ANALYSIS
    Panaccione, Remo
    Collins, Eric B.
    Melmed, Gil
    Vermeire, Severine
    Danese, Silvio
    Higgins, Peter D.
    Zhou, Wert
    Ilo, Dapo
    Sharma, Dolly
    Gonzalez, Yuri Sanchez
    Wang, Si-Tien
    GASTROENTEROLOGY, 2022, 162 (07) : S965 - S965
  • [30] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Xinqiao Chu
    Yaning Biao
    Chengjiang Liu
    Yixin Zhang
    Chenxu Liu
    Ji-zheng Ma
    Yufeng Guo
    Yaru Gu
    BMC Gastroenterology, 23
12345